TransCure bioServices Webinar 2020 Series on Inflammation
Informations

Event's date
28 May 2020
Event's place
Online

Sector associated
Inflammatory IBD

TransCure bioServices Webinar 2020 Series

Don’t miss the webinar on mouse models with the full human immune system for inflammatory diseases!

May 28th, 5pm to 6pm (Europe/Paris)

Inflammation: full human immune system mouse models and translational predictability.

The Do’s and Don’ts by the TransCure bioServices Experts.

Sebastien Tabruyn, PhD Chief Scientific Officer (CSOHosted online by
Sebastien Tabruyn, PhD, CSO
for a 45 minutes presentation and 15 minutes Q/A.

You will learn:

  • Which are the main characteristics of a predictive IBD full human immune system mouse model?
  • How to choose between chronic and acute hu-IBD?
  • Why is the hu-IBD model developed by TransCure bioServices superior to all constitutive mouse models?
  • Several case studies will be presented in detail: Diminution of Inflammatory symptoms with anti-huTNFa, Humira, CyclosporinA, Human leukocyte infiltration, hCD3/hCD4 infiltration…

Who is Sebastien Tabruyn?

Sebastien Tabruyn, PhD Chief Scientific Officer (CSO). He holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.

Who are we?

TransCure bioServices is the European Leader CRO specialized in the Advanced Human Immune System Mouse (hu-mouse) Models. We provides in vivo pharmacology preclinical services for Cancer/Immuno-oncology, HIV, Inflammatory Bowel Diseases, Vaccines/Immunization, Immuno-safety…

Highest needs for the large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases for translational potential assessment and better predictive activity in clinical studies.. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.


Share this!